The activist investor Elliott Advisors is pushing for GlaxoSmithKline to consider scrapping plans to list its toothpaste and painkillers business and explore a sale to a private equity consortium.
Read the full article on The Telegraph website (Paywall)
NAM Implication:
- Watch this space…
